Published in Br J Obstet Gynaecol on February 01, 1992
Antenatal maternal serum screening for Down's syndrome: results of a demonstration project. BMJ (1992) 9.08
Screening for Down's syndrome: effects, safety, and cost effectiveness of first and second trimester strategies. BMJ (2001) 4.15
When can a risk factor be used as a worthwhile screening test? BMJ (1999) 3.56
Maternal serum screening. Can Fam Physician (1994) 1.46
Prospective study of prenatal screening for Down's syndrome with free beta human chorionic gonadotrophin. BMJ (1993) 1.30
Risk assessment adjusted for gestational age in maternal serum screening for Down's syndrome. BMJ (1993) 1.10
Antenatal screening for Down's syndrome. BMJ (1993) 1.02
Maternal leisure-time exercise and timely delivery. Am J Public Health (1998) 0.93
Obesity and the risk and detection of fetal malformations. Semin Perinatol (2012) 0.85
Antenatal screening for Down's syndrome. BMJ (1992) 0.84
Korean-specific parameter models for calculating the risk of Down syndrome in the second trimester of pregnancy. J Korean Med Sci (2011) 0.81
Weight correction of MoM values: which method? J Clin Pathol (2006) 0.81
Association between altered placental human chorionic gonadotrophin (hCG) production and the occurrence of cryptorchidism: a retrospective study. BMC Pediatr (2014) 0.80
The triple test as a screening technique for Down syndrome: reliability and relevance. Int J Womens Health (2010) 0.79
Ultrasound Reference Chart Based on IVF Dates to Estimate Gestational Age at 6-9 weeks' Gestation. ISRN Obstet Gynecol (2012) 0.75
Maternal serum alphafetoprotein screening for open neural tube defects: revised statistical parameters. BJOG (2000) 0.75
Triple test screening for Down syndrome: an Egyptian-tailored study. PLoS One (2014) 0.75
Limitations of Aneuploidy and Anomaly Detection in the Obese Patient. J Clin Med (2014) 0.75
Is MoM bashing justified? Am J Hum Genet (1993) 0.75
Rational Down syndrome screening policy. Am J Public Health (1998) 0.75
Antenatal maternal serum screening for Down's syndrome: results of a demonstration project. BMJ (1992) 9.08
The Complex Carbohydrate Structure Database. Trends Biochem Sci (1989) 9.00
Maternal serum screening for Down's syndrome in early pregnancy. BMJ (1988) 8.65
A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1. Antimicrob Agents Chemother (2000) 8.54
Oral lesions in sheep and cattle in Dumfries and Galloway. Vet Rec (2001) 7.78
Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol (1987) 6.20
Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature (2000) 5.86
Altered fidelity of mitotic chromosome transmission in cell cycle mutants of S. cerevisiae. Genetics (1985) 5.75
Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. Nucleic Acids Res (1985) 5.22
The extent of Down's syndrome screening in Britain in 1991. Lancet (1992) 5.20
Control of acid resistance in Escherichia coli. J Bacteriol (1999) 4.93
Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus. Nature (1986) 4.70
A good practice guide to the administration of substances and removal of blood, including routes and volumes. J Appl Toxicol (2001) 4.39
Single-molecule studies of DNA mechanics. Curr Opin Struct Biol (2000) 4.39
Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J Clin Invest (1987) 4.26
Does breathing other people's tobacco smoke cause lung cancer? Br Med J (Clin Res Ed) (1986) 4.06
Analysis of yeast protein kinases using protein chips. Nat Genet (2000) 3.94
Maternal serum alpha-fetoprotein measurement: a screening test for Down syndrome. Lancet (1984) 3.91
Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy. Arch Virol (1998) 3.77
Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation. Cell (1999) 3.58
Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms. Environ Health Perspect (1998) 3.51
Assessment of commercial laboratories performing hair mineral analysis. JAMA (2001) 3.42
Temperate Bacteriophage Which Causes the Production of a New Major Outer Membrane Protein by Escherichia coli. J Virol (1975) 3.11
Down's syndrome screening in UK. Lancet (1996) 3.11
Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science (1998) 2.83
The spindle checkpoint of budding yeast depends on a tight complex between the Mad1 and Mad2 proteins. Mol Biol Cell (1999) 2.75
Retrohoming of a bacterial group II intron: mobility via complete reverse splicing, independent of homologous DNA recombination. Cell (1998) 2.74
AIDS and self-organization among intravenous drug users. Int J Addict (1987) 2.73
The National Health Service needs a voice of its own. J R Soc Med (2000) 2.65
Accreditation in transoesophageal echocardiography: statement from the Association of Cardiothoracic Anaesthetists and the British Society of Echocardiography Joint TOE Accreditation Committee. Br J Anaesth (2003) 2.64
A functional mitotic spindle prepared from mammalian cells in culture. Proc Natl Acad Sci U S A (1974) 2.64
Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome. Br J Obstet Gynaecol (1988) 2.62
Retrotransposition of a bacterial group II intron. Nature (2000) 2.51
Psychological interventions to improve adherence to oral hygiene instructions in adults with periodontal diseases. Cochrane Database Syst Rev (2007) 2.47
Amniotic-fluid acetylcholinesterase as a possible diagnostic test for neural-tube defects in early pregnancy. Lancet (1979) 2.42
Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry (2001) 2.40
Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. International Prenatal Screening Research Group. Br J Obstet Gynaecol (1996) 2.40
Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome. Br J Obstet Gynaecol (1988) 2.40
Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: results of a multicenter phase II trial. J Clin Oncol (1997) 2.39
Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count. JAMA (1998) 2.37
A nested-PCR-based schizodeme method for identifying Leishmania kinetoplast minicircle classes directly from clinical samples and its application to the study of the epidemiology of Leishmania tropica in Pakistan. J Clin Microbiol (1998) 2.35
Amino acid sequence of the alpha subunit of transducin deduced from the cDNA sequence. Proc Natl Acad Sci U S A (1985) 2.34
Patterns of differentiation and hybridization in North American wolflike canids, revealed by analysis of microsatellite loci. Mol Biol Evol (1994) 2.28
Hormone receptors: studies on the interaction of estrogen with the uterus. Recent Prog Horm Res (1968) 2.28
Identification of Harper-Cawston factor as thymidine phosphorylase and removal from media of substances interfering with susceptibility testing to sulfonamides and diaminopyrimidines. Antimicrob Agents Chemother (1975) 2.22
GDNF signalling through the Ret receptor tyrosine kinase. Nature (1996) 2.21
The natural history of treated and untreated primary hyperparathyroidism: the parathyroid epidemiology and audit research study. QJM (2011) 2.20
Severe adverse life events and depressive symptoms among women with, or at risk for, HIV infection in four cities in the United States of America. AIDS (1999) 2.20
Randomized phase II study of two gemcitabine schedules for patients with impaired performance status (Karnofsky performance status </= 70) and advanced non-small-cell lung cancer. J Clin Oncol (2005) 2.17
An association between type 1 diabetes and idiopathic generalized epilepsy. Ann Neurol (2006) 2.15
Measurement and characterization of postischemic free radical generation in the isolated perfused heart. J Biol Chem (1989) 2.14
Observations in the Haight-Ashbury Medical Clinic of San Francisco. Health problems in a "hippie" subculture. Clin Pediatr (Phila) (1968) 2.12
Ribonuclease P: function and variation. J Biol Chem (1990) 2.07
Antenatal screening in Oxford for fetal neural tube defects. Br J Obstet Gynaecol (1979) 2.06
Biological properties of a CD4 immunoadhesin. Nature (1990) 2.05
Differential distribution of 5HT1D- and 5HT1B-immunoreactivity within the human trigemino-cerebrovascular system: implications for the discovery of new antimigraine drugs. Cephalalgia (1997) 1.99
Insulin resistance in uremia. J Clin Invest (1981) 1.98
First trimester concentrations of pregnancy associated plasma protein A and placental protein 14 in Down's syndrome. BMJ (1992) 1.95
Recent advances in screening for neural tube defects and Down's syndrome. Baillieres Clin Obstet Gynaecol (1987) 1.93
An outcome analysis of 100 women after explantation of silicone gel breast implants. Ann Plast Surg (1997) 1.93
Maternal serum free beta-human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndrome. Prenat Diagn (1994) 1.92
Effect of treatment with cyclosporine versus azathioprine on incidence and severity of cytomegalovirus infection posttransplantation. Transplantation (1985) 1.90
Classifying general medicine readmissions. Are they preventable? Veterans Affairs Cooperative Studies in Health Services Group on Primary Care and Hospital Readmissions. J Gen Intern Med (1996) 1.89
Control of oxidative metabolism and oxygen delivery in human skeletal muscle: a steady-state analysis of the work/energy cost transfer function. Proc Natl Acad Sci U S A (1985) 1.86
Circadian regulation of cAMP response element-mediated gene expression in the suprachiasmatic nuclei. J Biol Chem (1999) 1.85
Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res (1994) 1.84
Coronary angioplasty versus medical therapy for angina. Health service costs based on the second Randomized Intervention Treatment of Angina (RITA-2) trial. Eur Heart J (2002) 1.83
Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature. Health Technol Assess (2001) 1.82
Identifying and separating the effects of practice and of cognitive ageing during a large longitudinal study of elderly community residents. Neuropsychologia (2001) 1.81
Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol (1986) 1.80
A novel addition to the T cell repertory. Cell surface expression of tumor necrosis factor/cachectin by activated normal human T cells. J Exp Med (1990) 1.80
Rules for DNA target-site recognition by a lactococcal group II intron enable retargeting of the intron to specific DNA sequences. Genes Dev (2000) 1.80
Membrane-dependent cleavage of the human placental lactogen precursor to its native form in ascites cell-free extracts. Eur J Biochem (1977) 1.79
Alpha fetoprotein in the antenatal diagnosis of open neural tube defects. Br J Hosp Med (1980) 1.79
Mapping the actin filament with myosin. Proc Natl Acad Sci U S A (2001) 1.79
Multicenter epidemiologic and health services research on therapeutics in the HMO Research Network Center for Education and Research on Therapeutics. Pharmacoepidemiol Drug Saf (2002) 1.79
Estimation of linkage disequilibrium in a sample of the United Kingdom dairy cattle population using unphased genotypes. J Anim Sci (2003) 1.77
Psychosocial aspects of genetic screening of pregnant women and newborns: a systematic review. Health Technol Assess (2004) 1.77
Active fluidization of polymer networks through molecular motors. Nature (2002) 1.77
Routine pelvic x-ray studies in awake blunt trauma patients: a sensible policy? J Trauma (1992) 1.72
A cross-national comparison of the impact of family migration on women's employment status. Demography (2001) 1.71
Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia. J Infect Dis (1999) 1.70
Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials. Br J Cancer (2009) 1.69
Reference values of normal cerebrospinal fluid composition in infants ages 0 to 8 weeks. Pediatr Infect Dis J (1992) 1.67
The relationship between beliefs about nutrition and dietary practices of the elderly. J Am Diet Assoc (1990) 1.67
Age-related impairment of synaptic transmission but normal long-term potentiation in transgenic mice that overexpress the human APP695SWE mutant form of amyloid precursor protein. J Neurosci (2001) 1.65
The pathophysiological changes in the bladder obstructed by benign prostatic hyperplasia. Br J Urol (1994) 1.64
Fluconazole resistant candida in AIDS. J Infect (1991) 1.64
Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the Bone Marrow Transplant Survivor Study. Bone Marrow Transplant (2006) 1.63
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin. Prenat Diagn (1995) 1.60
Runaway pacemaker rhythm after 36 hours of electrical inactivity. Br Heart J (1974) 1.60
Overwintering Trends of Cold Resistance and Carbohydrates in Medium Red, Ladino, and Common White Clover. Plant Physiol (1956) 1.59
Inflammatory leukocytic recruitment and diffuse neuronal degeneration are separate pathological processes resulting from traumatic brain injury. J Neurosci (1995) 1.59